Show Search Form
human indexable | ||||||||
---|---|---|---|---|---|---|---|---|
published | ||||||||
registered interest | ||||||||
answer date | ||||||||
date | ||||||||
date tabled | ||||||||
ddp created | ||||||||
answering body |
|
|||||||
question status | Tabled | |||||||
answering dept id | 17 | |||||||
answering dept short name | Health and Social Care | |||||||
answering dept sort name | Health and Social Care | |||||||
ddp modified |
|
|||||||
hansard heading | Human Embryo Experiments: Regulation | |||||||
house id | 2 | |||||||
identifier | HL16935 | |||||||
legislature |
|
|||||||
parliament number | 57 | |||||||
question first answered |
|
|||||||
question text | To ask Her Majesty's Government, further to the Written Answer by Earl Howe on 9 October 2013 (HL2237), what assessment the Scientific and Clinical Advances Advisory Committee of the Human Fertilisation and Embryology Authority has made of the regulation of embryoid bodies following the publication of research (1) by Lancaster et al. Cerebral organoids model human brain development and microcephaly in 2013, and (2) in the Nature Cell Biology journal A 3D model of a human epiblast reveals BMP4-driven symmetry breaking on 1 July. | |||||||
session |
|
|||||||
session number | 1 | |||||||
tabling member printed |
|
|||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL16935 | |||||||
type |
|
|||||||
uin | HL16935 | |||||||
version | 1 | |||||||
written parliamentary question type | Ordinary | |||||||
answer | answer | |||||||
creator |
|
|||||||
publisher | 25277 | |||||||
tabling member |
|